WO2016004280A3 - Inhibiteurs de tyrosine kinase de bruton - Google Patents

Inhibiteurs de tyrosine kinase de bruton Download PDF

Info

Publication number
WO2016004280A3
WO2016004280A3 PCT/US2015/038947 US2015038947W WO2016004280A3 WO 2016004280 A3 WO2016004280 A3 WO 2016004280A3 US 2015038947 W US2015038947 W US 2015038947W WO 2016004280 A3 WO2016004280 A3 WO 2016004280A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitors
btk
tyrosine kinase
bruton
irreversible
Prior art date
Application number
PCT/US2015/038947
Other languages
English (en)
Other versions
WO2016004280A2 (fr
Inventor
Wei Chen
Zhaozhong J. Jia
Original Assignee
Pharmacyclics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacyclics Llc filed Critical Pharmacyclics Llc
Publication of WO2016004280A2 publication Critical patent/WO2016004280A2/fr
Publication of WO2016004280A3 publication Critical patent/WO2016004280A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin

Abstract

L'invention concerne des composés hétéroaryle en tant qu'inhibiteurs de kinase. Des méthodes de synthèse de tels inhibiteurs et des méthodes d'utilisation de ces inhibiteurs dans le traitement de maladies sont également décrits.
PCT/US2015/038947 2014-07-02 2015-07-02 Inhibiteurs de tyrosine kinase de bruton WO2016004280A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462019977P 2014-07-02 2014-07-02
US62/019,977 2014-07-02

Publications (2)

Publication Number Publication Date
WO2016004280A2 WO2016004280A2 (fr) 2016-01-07
WO2016004280A3 true WO2016004280A3 (fr) 2016-03-10

Family

ID=55020101

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/038947 WO2016004280A2 (fr) 2014-07-02 2015-07-02 Inhibiteurs de tyrosine kinase de bruton

Country Status (1)

Country Link
WO (1) WO2016004280A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI815137B (zh) * 2018-06-15 2023-09-11 漢達生技醫藥股份有限公司 尼洛替尼十二烷基硫酸鹽之結晶
WO2020113094A1 (fr) 2018-11-30 2020-06-04 Nuvation Bio Inc. Composés pyrrole et pyrazole et leurs procédés d'utilisation
JP7475370B2 (ja) 2019-05-10 2024-04-26 河南知微生物医薬有限公司 ブルトン型チロシンキナーゼ阻害剤としての置換されている１－アミノ－１ｈ－イミダゾール－５－カルボキサミド

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100768A1 (en) * 2000-12-13 2003-05-29 Han Amy Qi Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
WO2014082598A1 (fr) * 2012-11-30 2014-06-05 Centaurus Biopharma Co., Ltd. Inhibiteurs de la tyrosine kinase de bruton

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100768A1 (en) * 2000-12-13 2003-05-29 Han Amy Qi Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
WO2014082598A1 (fr) * 2012-11-30 2014-06-05 Centaurus Biopharma Co., Ltd. Inhibiteurs de la tyrosine kinase de bruton

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAHM ET AL.: "An Efficient Synthesis of Enantiomerically Pure Functionalized Imidazolidin-2-ones from Chiral Aziridines: Supplementary Information.", THE ROYAL SCIENCE OF CHEMISTRY, 2005, Retrieved from the Internet <URL:http://www.rsc.org/suppdata/cc/b5/b503750f/b503750f.pdf> [retrieved on 20150902] *

Also Published As

Publication number Publication date
WO2016004280A2 (fr) 2016-01-07

Similar Documents

Publication Publication Date Title
PH12018501151A1 (en) Tank-binding kinase inhibitor compounds
MX2022002579A (es) Compuestos de aminotiazol como inhibidores de c- kit.
MX2017016655A (es) Formulaciones oftalmicas de inhibidores de tirosina quinasa, metodos de uso de las mismas y metodos de preparacion de las mismas.
PH12017550028A1 (en) Solid forms of an ask1 inhibitor
TN2015000417A1 (en) Heteroaryl compounds and uses thereof
MX2015011514A (es) Compuestos de heteroarilo y sus usos.
IL248546A0 (en) A polysubstituted fluorine compound as a proton tyrosine kinase inhibitor
NZ729603A (en) Heteroaryl compounds as btk inhibitors and uses thereof
EP3544959A4 (fr) Dégradation de la tyrosine kinase de bruton (btk) par conjugaison d&#39;inhibiteurs de btk avec un ligand de la ligase e3 et procédés d&#39;utilisation
MX2016015862A (es) Compuestos inhibidores de la cinasa de union a tank.
WO2016196776A3 (fr) Inhibiteurs de la tyrosine kinase de bruton
WO2016004305A3 (fr) Inhibiteurs de la tyrosine kinase de bruton
WO2015048689A8 (fr) Inhibiteurs de la tyrosine kinase de bruton
WO2016105525A3 (fr) Nouvelles pyrimidines en tant qu&#39;inhibiteurs d&#39;egfr et procédés de traitement de troubles
EP3414234A4 (fr) Inhibiteurs de la tyrosine kinase de bruton
HUE060152T2 (hu) 4-(3H-indol-5-il)-N-(piridin-2-il)pirimidin-2-amin-származékok mint proteinkináz inhibitorok, elõállítási eljárásuk és gyógyászati alkalmazásuk
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
EP3174539A4 (fr) Inhibiteurs de la tyrosine kinase de bruton
MX2015015422A (es) Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos.
PH12016502523A1 (en) Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
MX2017003930A (es) Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank.
MX2018008815A (es) Inhibidores de tirosina quinasa de bruton.
PH12017502236A1 (en) 2-(pyrazolopyridin-3-yl)pyrimidine derivatives as jak inhibitors
EA201591794A1 (ru) Макроциклические ингибиторы соль-индуцируемых киназ
JO3793B1 (ar) مثبطات تيروزين كاينيز بروتون وأساليب استخدامها

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15815146

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15815146

Country of ref document: EP

Kind code of ref document: A2